Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F19%3AN0000031" target="_blank" >RIV/00064173:_____/19:N0000031 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/19:10395608 RIV/00064203:_____/19:10395608

Výsledek na webu

<a href="https://doi.org/10.21873/invivo.11571" target="_blank" >https://doi.org/10.21873/invivo.11571</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.21873/invivo.11571" target="_blank" >10.21873/invivo.11571</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

Popis výsledku v původním jazyce

Circulating tumor cells (CTCs), detached from the primary tumor or metastases and shed in the patient's bloodstream, represent a relatively easily obtainable sample of the cancer tissue that can indicate the actual state of cancer, and their evaluation can be repeated many times during the course of treatment. As part of liquid biopsy, evaluation of CTCs provides a lot of clinically relevant information, which reflects the actual, real-time conditions of the disease. CTCs can be used in cancer diagnosis or screening, real-time long-term disease monitoring and even therapy guidance. Their analysis can include their number, morphology, and biological features by using immunocytochemistry and all "-omic" technologies. This review describes methods of CTC isolation and potential clinical utilization in lung cancer.

Název v anglickém jazyce

Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

Popis výsledku anglicky

Circulating tumor cells (CTCs), detached from the primary tumor or metastases and shed in the patient's bloodstream, represent a relatively easily obtainable sample of the cancer tissue that can indicate the actual state of cancer, and their evaluation can be repeated many times during the course of treatment. As part of liquid biopsy, evaluation of CTCs provides a lot of clinically relevant information, which reflects the actual, real-time conditions of the disease. CTCs can be used in cancer diagnosis or screening, real-time long-term disease monitoring and even therapy guidance. Their analysis can include their number, morphology, and biological features by using immunocytochemistry and all "-omic" technologies. This review describes methods of CTC isolation and potential clinical utilization in lung cancer.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10608 - Biochemistry and molecular biology

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

In Vivo

ISSN

0258-851X

e-ISSN

1791-7549

Svazek periodika

33

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

GR - Řecká republika

Počet stran výsledku

11

Strana od-do

1027-1037

Kód UT WoS článku

000474906500004

EID výsledku v databázi Scopus

2-s2.0-85069292699